Beta2-microglobulin(B2M) in cancer immunotherapies: Biological function, resistance and remedy
出版年份 2021 全文链接
标题
Beta2-microglobulin(B2M) in cancer immunotherapies: Biological function, resistance and remedy
作者
关键词
β2-microglobulin, Major histocompatibility complex class I, Microsatellite instability, Immune checkpoint inhibition
出版物
CANCER LETTERS
Volume 517, Issue -, Pages 96-104
出版商
Elsevier BV
发表日期
2021-06-13
DOI
10.1016/j.canlet.2021.06.008
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Biomarker Discovery in Patients with Immunotherapy-Treated Melanoma with Imaging Mass Cytometry
- (2021) Sandra Martinez-Morilla et al. CLINICAL CANCER RESEARCH
- Spatial analysis and clinical significance of HLA class-I and class-II subunit expression in non-small cell lung cancer
- (2021) Ila J Datar et al. CLINICAL CANCER RESEARCH
- The role of KIR positive NK cells in diseases and its importance in clinical intervention
- (2021) Khadijeh Dizaji Asl et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- CD4 T cell dependent rejection of beta 2 microglobulin null mismatch repair deficient tumors
- (2021) Giovanni Germano et al. Cancer Discovery
- ‘Off-the-shelf’ allogeneic CAR T cells: development and challenges
- (2020) S. Depil et al. NATURE REVIEWS DRUG DISCOVERY
- Clinical and molecular correlates of PD-L1 expression in patients with lung adenocarcinomas
- (2020) A.J. Schoenfeld et al. ANNALS OF ONCOLOGY
- Durable response to combination radiotherapy and immunotherapy in EP-resistant lung large-cell neuroendocrine carcinoma with B2M and STK11 mutations: a case report
- (2020) Yi Qin et al. Immunotherapy
- Cytokine network analysis of immune responses before and after autologous dendritic cell and tumor cell vaccine immunotherapies in a randomized trial
- (2020) Gabriel I. Nistor et al. Journal of Translational Medicine
- Overcoming genetically-based resistance mechanisms to PD-1 blockade
- (2020) Davis Y. Torrejon et al. Cancer Discovery
- Inhibition of MICA and MICB Shedding Elicits NK-Cell–Mediated Immunity against Tumors Resistant to Cytotoxic T Cells
- (2020) Lucas Ferrari de Andrade et al. Cancer Immunology Research
- Sequential ctDNA whole-exome sequencing in advanced lung adenocarcinoma with initial durable tumor response on immune checkpoint inhibitor and late progression
- (2020) Etienne Giroux Leprieur et al. Journal for ImmunoTherapy of Cancer
- Implications of Hereditary Origin on the Immune Phenotype of Mismatch Repair-Deficient Cancers: Systematic Literature Review
- (2020) Lena Bohaumilitzky et al. Journal of Clinical Medicine
- The shared frameshift mutation landscape of microsatellite-unstable cancers suggests immunoediting during tumor evolution
- (2020) Alexej Ballhausen et al. Nature Communications
- Abrogation of HLA surface expression using CRISPR/Cas9 genome editing: a step toward universal T cell therapy
- (2020) Jeewon Lee et al. Scientific Reports
- Gene signature of antigen processing and presentation machinery predicts response to checkpoint blockade in non-small cell lung cancer (NSCLC) and melanoma
- (2020) Jeffrey C Thompson et al. Journal for ImmunoTherapy of Cancer
- ESMO recommendations on microsatellite instability testing for immunotherapy in cancer, and its relationship with PD-1/PD-L1 expression and tumour mutational burden: a systematic review-based approach
- (2019) C Luchini et al. ANNALS OF ONCOLOGY
- Confirmation that somatic mutations of beta‐2 microglobulin correlate with a lack of recurrence in a subset of stage II mismatch repair deficient colorectal cancers from the QUASAR trial
- (2019) P. Barrow et al. HISTOPATHOLOGY
- Impact of epitope density on CD8+ T cell development and function
- (2019) Gabriela L. Cosma et al. MOLECULAR IMMUNOLOGY
- Radiation therapy and anti-tumor immunity: exposing immunogenic mutations to the immune system
- (2019) Claire Lhuillier et al. Genome Medicine
- Intrinsic Resistance to Immune Checkpoint Blockade in a Mismatch Repair–Deficient Colorectal Cancer
- (2019) Carino Gurjao et al. Cancer Immunology Research
- Microsatellite instability and immune checkpoint inhibitors: toward precision medicine against gastrointestinal and hepatobiliary cancers
- (2019) Yuji Eso et al. JOURNAL OF GASTROENTEROLOGY
- The inhibitory receptor CD94/NKG2A on CD8+ tumor-infiltrating lymphocytes in colorectal cancer: a promising new druggable immune checkpoint in the context of HLAE/β2m overexpression
- (2019) Juliette Eugène et al. MODERN PATHOLOGY
- Efficacy of adoptive therapy with tumor-infiltrating lymphocytes and recombinant interleukin-2 in advanced cutaneous melanoma: a systematic review and meta-analysis
- (2019) U Dafni et al. ANNALS OF ONCOLOGY
- MHC-II neoantigens shape tumour immunity and response to immunotherapy
- (2019) Elise Alspach et al. NATURE
- Genetic and epigenetic analysis of the beta-2-microglobulin gene in microsatellite instable colorectal cancer
- (2019) Zuzana Snahnicanova et al. CLINICAL AND EXPERIMENTAL MEDICINE
- High mutational burden in colorectal carcinomas with monoallelic POLE mutations: absence of allelic loss and gene promoter methylation
- (2019) Maja Hühns et al. MODERN PATHOLOGY
- Genomic Features of Response to Combination Immunotherapy in Patients with Advanced Non-Small-Cell Lung Cancer
- (2018) Matthew D. Hellmann et al. CANCER CELL
- The transition from HLA-I positive to HLA-I negative primary tumors: the road to escape from T-cell responses
- (2018) Natalia Aptsiauri et al. CURRENT OPINION IN IMMUNOLOGY
- Polymerase epsilon mutations and concomitant β2-microglobulin mutations in cancer
- (2018) Ioannis A. Voutsadakis GENE
- Molecular Determinants of Response to Anti–Programmed Cell Death (PD)-1 and Anti–Programmed Death-Ligand 1 (PD-L1) Blockade in Patients With Non–Small-Cell Lung Cancer Profiled With Targeted Next-Generation Sequencing
- (2018) Hira Rizvi et al. JOURNAL OF CLINICAL ONCOLOGY
- Cancer immunotherapy using checkpoint blockade
- (2018) Antoni Ribas et al. SCIENCE
- MHC proteins confer differential sensitivity to CTLA-4 and PD-1 blockade in untreated metastatic melanoma
- (2018) Scott J. Rodig et al. Science Translational Medicine
- Genetic Mechanisms of Immune Evasion in Colorectal Cancer
- (2018) Catherine S. Grasso et al. Cancer Discovery
- HLA class I alterations in breast carcinoma are associated with a high frequency of the loss of heterozygosity at chromosomes 6 and 15
- (2018) María A. Garrido et al. IMMUNOGENETICS
- Immunoprofiles of colorectal cancer from Lynch syndrome
- (2018) Joanna Walkowska et al. OncoImmunology
- Biological Consequences of Major Histocompatibility Class-II Expression by Tumor Cells in Cancer
- (2018) Margaret L Axelrod et al. CLINICAL CANCER RESEARCH
- Inducible down-regulation of MHC class I results in natural killer cell tolerance
- (2018) Michael D. Bern et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Loss of ADAR1 in tumours overcomes resistance to immune checkpoint blockade
- (2018) Jeffrey J. Ishizuka et al. NATURE
- Cancer immunoediting and resistance to T cell-based immunotherapy
- (2018) Jake S. O’Donnell et al. Nature Reviews Clinical Oncology
- Somatic mutations of the coding microsatellites within the beta-2-microglobulin gene in mismatch repair-deficient colorectal cancers and adenomas
- (2017) Mark Clendenning et al. Familial Cancer
- Personalized RNA mutanome vaccines mobilize poly-specific therapeutic immunity against cancer
- (2017) Ugur Sahin et al. NATURE
- Tumor Mutational Burden and Response Rate to PD-1 Inhibition
- (2017) Mark Yarchoan et al. NEW ENGLAND JOURNAL OF MEDICINE
- Mismatch repair deficiency predicts response of solid tumors to PD-1 blockade
- (2017) Dung T. Le et al. SCIENCE
- Mechanisms and Dynamics of T Cell-Mediated Cytotoxicity In Vivo
- (2017) Stephan Halle et al. TRENDS IN IMMUNOLOGY
- IL-21-mediated reversal of NK cell exhaustion facilitates anti-tumour immunity in MHC class I-deficient tumours
- (2017) Hyungseok Seo et al. Nature Communications
- Resistance to checkpoint blockade therapy through inactivation of antigen presentation
- (2017) Moshe Sade-Feldman et al. Nature Communications
- Impaired HLA Class I Antigen Processing and Presentation as a Mechanism of Acquired Resistance to Immune Checkpoint Inhibitors in Lung Cancer
- (2017) Scott Gettinger et al. Cancer Discovery
- High numbers of PDCD1 (PD-1)-positive T cells and B2M mutations in microsatellite-unstable colorectal cancer
- (2017) Jonas Janikovits et al. OncoImmunology
- Suppression of Type I IFN Signaling in Tumors Mediates Resistance to Anti-PD-1 Treatment That Can Be Overcome by Radiotherapy
- (2016) Xiaohong Wang et al. CANCER RESEARCH
- Genomic Profiling of Patient-Derived Xenografts for Lung Cancer Identifies B2M Inactivation Impairing Immunorecognition
- (2016) Carolina Pereira et al. CLINICAL CANCER RESEARCH
- Multiplex Genome Editing to Generate Universal CAR T Cells Resistant to PD1 Inhibition
- (2016) Jiangtao Ren et al. CLINICAL CANCER RESEARCH
- The urgent need to recover MHC class I in cancers for effective immunotherapy
- (2016) Federico Garrido et al. CURRENT OPINION IN IMMUNOLOGY
- Integrative Analyses of Colorectal Cancer Show Immunoscore Is a Stronger Predictor of Patient Survival Than Microsatellite Instability
- (2016) Bernhard Mlecnik et al. IMMUNITY
- The absence of HLA class I expression in non-small cell lung cancer correlates with the tumor tissue structure and the pattern of T cell infiltration
- (2016) Francisco Perea et al. INTERNATIONAL JOURNAL OF CANCER
- Mutations Associated with Acquired Resistance to PD-1 Blockade in Melanoma
- (2016) Jesse M. Zaretsky et al. NEW ENGLAND JOURNAL OF MEDICINE
- NLRC5/MHC class I transactivator is a target for immune evasion in cancer
- (2016) Sayuri Yoshihama et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Molecular and Genetic Properties of Tumors Associated with Local Immune Cytolytic Activity
- (2015) Michael S. Rooney et al. CELL
- β2-Microglobulin deficiency causes a complex immunodeficiency of the innate and adaptive immune system
- (2015) Ömür Ardeniz et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- PD-1 Blockade in Tumors with Mismatch-Repair Deficiency
- (2015) Dung T. Le et al. NEW ENGLAND JOURNAL OF MEDICINE
- Genetic Evolution of T-cell Resistance in the Course of Melanoma Progression
- (2014) A. Sucker et al. CLINICAL CANCER RESEARCH
- Cytokine therapy reverses NK cell anergy in MHC-deficient tumors
- (2014) Michele Ardolino et al. JOURNAL OF CLINICAL INVESTIGATION
- The Adaptable Major Histocompatibility Complex (MHC) Fold: Structure and Function of Nonclassical and MHC Class I–Like Molecules
- (2013) Erin J. Adams et al. Annual Review of Immunology
- Immune escape of cancer cells with beta2-microglobulin loss over the course of metastatic melanoma
- (2013) Ana B. del Campo et al. INTERNATIONAL JOURNAL OF CANCER
- Germline and somatic polymerase ϵ and δ mutations define a new class of hypermutated colorectal and endometrial cancers
- (2013) Sarah Briggs et al. JOURNAL OF PATHOLOGY
- Implication of the β2-microglobulin gene in the generation of tumor escape phenotypes
- (2012) Monica Bernal et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Infiltration of Lynch Colorectal Cancers by Activated Immune Cells Associates with Early Staging of the Primary Tumor and Absence of Lymph Node Metastases
- (2012) Noel F.C.C. de Miranda et al. CLINICAL CANCER RESEARCH
- Melanoma genome sequencing reveals frequent PREX2 mutations
- (2012) Michael F. Berger et al. NATURE
- Cancer Immunoediting: Integrating Immunity's Roles in Cancer Suppression and Promotion
- (2011) R. D. Schreiber et al. SCIENCE
- Frequent loss of heterozygosity in the β2-microglobulin region of chromosome 15 in primary human tumors
- (2010) Isabel Maleno et al. IMMUNOGENETICS
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started